| Olivia Michelle King, LPN | |
|
125 E Township St, Suite 1, Fayetteville, AR 72703-2817 | |
| (479) 443-7791 | |
| (479) 443-7791 |
| Full Name | Olivia Michelle King |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 125 E Township St, Fayetteville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972615417 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | L38828 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Olivia Michelle King, LPN Po Box 173, Oaks, OK 74359-0173 Ph: () - | Olivia Michelle King, LPN 125 E Township St, Suite 1, Fayetteville, AR 72703-2817 Ph: (479) 443-7791 |
News Archive
The 2009/2010 Influenza A (H1N1) is one of several viruses responsible for respiratory-related infections. A new study from Rhode Island Hospital examined patients with viruses and found distinguishing characteristics of the H1N1 virus in how it affects respiratory illness. Their findings will be presented at the annual meeting of the Infectious Diseases Society of America to be held in Vancouver, Canada on Friday, Oct. 22.
The UK Medicines and Healthcare products Regulatory Agency advised that patients with certain artificial hips need annual tests to check for metal ions and MRIs if they show symptoms. The new guidelines follow reports from doctors of swelling and tissue damage in some patients with metal-on-metal hip implants. The update applies to those in Britain with a hip replacement with a head diameter of 36 millimetres or more. The MHRA said on Tuesday that around 49,000 UK patients with large-head hip implants out of 65,000 with all-metal hips were in a high-risk category.
Ceregene, a biopharmaceutical company, announced today that it is progressing with enrollment and dosing in its CERE-120 Phase 2b multi-center, sham-surgery, double-blinded controlled trial in Parkinson's disease.
The Cancer Prevention & Research Institute of Texas has awarded nearly $5.7 million in grants to The University of Texas Health Science Center at Houston School of Public Health. The grants will fund projects that train innovative cancer researchers, increase breast and cervical cancer screening among Hispanics and raise awareness about the human papillomavirus (HPV) vaccine.
› Verified 5 days ago
Elizabeth Dena Bell, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3715 N Business Dr, Fayetteville, AR 72703 Phone: 479-521-1532 | |
Sharon Byrd, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 17836 Harmon Rd, Fayetteville, AR 72704 Phone: 479-466-4546 |